language.en-US
  • EN
  • RU
Drug-resistant TB treatment and pregnancy

The webinar agenda includes:

  • - Welcoming remarks. Dr Askar Yedilbayev, Team Lead (TB), Mr Oleksandr Korotych, Technical Officer, Joint Infectious Diseases Unit, WHO Regional Office for Europe, Denmark.
  • - Key principles of management of drug-resistant tuberculosis in pregnant and peripartum people, Dr Jenifer Furin, Harvard Medical School, Department of Global Health and Social Medicine, The Sentinel Project on Paediatric Drug-Resistant Tuberculosis.
  • - Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin-resistant tuberculosis. Dr Marian Loveday, senior specialist scientist in the HIV and other Infectious Diseases Research Unit at the South African Medical Research Council, South Africa.
  • - Experience of Tajikistan in treatment with modified shorter RR-TB regimen during pregnancy. Dr Firuza Saidova, researcher, Tajikistan.
  • - Questions and Answers

 

1 Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin-resistant tuberculosis (1).pdf 2 Key principles of management of drug-resistant tuberculosis in pregnant and peripartum people (1).pdf 3. Experience of Tajikistan_Saidova_ENG.pdf 1 Воздействие бедаквилина при беременности и грудном вскармливании у женщин с туберкулезом, устойчивым к рифампицину.pdf 2 Основные принципы ведения лекарственно-устойчивого туберкулеза во время беременности и послеродовый период.pdf 3. Experience of Tajikistan_Saidova_RUS.pdf